Earlier today I posted a write-up on my blog regarding Cel-Sci Corp (CVM) and the company's potential for Multikine, a potential billion-dollar blockbuster if proven successful in a Phase III head and neck cancer trial for which we may see imminent results. I also discussed Cel-Sci's LEAPS platform, an immunotherapy treatment that had been looked at previously to treat the H1N1 flu years ago. If you haven't checked out that blog post already, you might as well now. It's a decent read.
Click the Read More link below to a follow-up post regarding today's news about LEAPS for the potential treatment of Coronavirus and how it will / could / should affect the CVM share price moving forward.
Airfares are cheap these days, plan for that post-lockdown vacation now! Put those stock winnings to good use!Travel, see the world and get some great airfare deals!